Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people ...

Olympus announced today that it launched its Olysense platform with Caddie medical device software for early colorectal polyp ...

Small in situ polyps of the rectosigmoid tract diagnosed during computer-assisted colonoscopy can be left alone without compromising oncologic safety if optically predicted by an endoscopist to be non ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

New research from BIDMC and Stanford reveals how nasal polyps form in chronic sinusitis, offering hope for improved care and treatment options. Read more.

Lyra Therapeutics (LYRA) announced the Company’s clinical plan and upcoming oral presentation of results from the positive Phase 3 ENLIGHTEN 2 ...

A leading US doctor emphasizes that a simple, routine test – colonoscopy can detect colon cancer early, significantly ...

Colorectal cancer is projected to cause 1.6 million deaths and 3.2 million new cases annually by 2040, according to the World ...

Scientists Uncover the "Cellular Conspiracy" Behind Chronic Sinus DiseaseBOSTON — Chronic rhinosinusitis (CRS) is a surprisingly common but ...

Lyra also announced a late-breaking oral presentation of the positive ENLIGHTEN 2 Phase 3 results at the Annual Meeting of the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), ...

An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why approval looks likely.

AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).